Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma

This publication has 36 references indexed in Scilit:

• ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy
  European Journal Of Cancer, 2000
• Primary Systemic Treatment with Weekly Doxorubicin Monotherapy in Women with Locally Advanced Breast Cancer; Clinical Experience and Parameters Predicting Outcome
  Acta Oncologica, 1996
• Pathologic Predictors of Tumor Response to Preoperative Chemotherapy in Locally Advanced Breast Carcinoma
  The Breast Journal, 1995
• Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast
  Cancer, 1994
• Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates
  European Journal Of Cancer, 1993
• Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or More
  JNCI Journal of the National Cancer Institute, 1990
• Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy
  Breast Cancer Research and Treatment, 1990
• HER2/neu AMPLIFICATION AND COMEDO TYPE BREAST CARCINOMA
  The Lancet, 1989
• Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
  Cancer, 1988
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987